User Tools
clinic_prep
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| clinic_prep [2024/02/29 21:05] – admin | clinic_prep [2024/03/09 00:25] (current) – removed admin | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ======new====== | ||
| - | * 1230 | ||
| - | * < | ||
| - | * 74M GOLD 1E COPD on triple w hyperinf and air trap, osa, active tud | ||
| - | * copd: triple inh | ||
| - | * tud: psych for nrt | ||
| - | * 4 mm rul nodule: lmc (dn dec 2023) | ||
| - | * hcm: rsv, pcv20, flu | ||
| - | * | ||
| - | * 1300 | ||
| - | * < | ||
| - | * 1330 | ||
| - | * < | ||
| - | * pulmonary and cardiac sarcoidosis | ||
| - | * GERD W H2R | ||
| - | * if no better, pred 20, 15, 10, | ||
| - | * ct chest | ||
| - | * fu in 6 weeks | ||
| - | * bill grier | ||
| - | * 1400 | ||
| - | * eustace8554(9/ | ||
| - | * chornic cough. worse at night. imporved w upright | ||
| - | * given albuteorla nd wixela. mildly better. | ||
| - | * h pylori fecal antigen | ||
| - | * cont inhalers | ||
| - | * pft in future if negative | ||
| - | * bill grier | ||
| - | * 1430 | ||
| - | * felder7071(8/ | ||
| - | * dlbcl, rcc sp left nephrect. niCM ef 30%, TUD | ||
| - | * mod restrict on PFT (65%); DLCO 37% | ||
| - | * recent admission for CHFe | ||
| - | * feels great; wants to come back PRN | ||
| - | * ref to pulmonary aprt | ||
| - | * bill grier | ||
| - | * 1500 | ||
| - | * marin7446(5/ | ||
| - | * severe persistent asthma | ||
| - | * on trelegy | ||
| - | * started on fasenra; doing great | ||
| - | * no changes; fu in 3 months | ||
| - | * if better then, triple --> LABA ICS | ||
| - | * jen so | ||
| - | * 1530 | ||
| - | * franklin0127(6/ | ||
| - | * 45M w hx of inhaled meth in rem, tud 20 PY in rem, active TUD. HIv on biktarvy | ||
| - | * | ||
| - | * 1600 | ||
clinic_prep.1709240748.txt.gz · Last modified: 2024/02/29 21:05 by admin
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Share Alike 4.0 International
